Skip to main content
Clinical Trials/CTRI/2019/12/022286
CTRI/2019/12/022286
Not yet recruiting
Phase 2

CLINICAL EVALUATION AND THERAPEUTIC MANAGEMENT OF MANTHA SANNI(AUTISM SPECTRUM DISORDER) WITH AMUKKARA CHOORANAM AND YEGAMOOLI THYLAM THUVALAI IN CHILDRE

ational Institute of Siddha0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders
Sponsor
ational Institute of Siddha
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Clinically diagnosed as autism spectrum disorder ASD Meets diagnostic symptoms of poor eye contact inappropriate emotional response acquired speech or lost it engages in stereotyped and repetitive behaviour unusual sensitive to sensory stimuli

Exclusion Criteria

  • The conditions that co occur with ASD
  • Attention deficit hyperactivity disorder ADHD
  • Cerebral palsy Hearing and visual impairments congenital anomalies
  • Any other serious illness

Outcomes

Primary Outcomes

Not specified

Similar Trials